The U.S. Food and Drug Administration has approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor ...

Get Latest News, Breaking News about Global Drug Supply Chain. Stay connected to all updated on Global Drug Supply Chain ...

As marijuana use becomes more common and legal in most U.S. states, patients who use cannabis may face a significantly higher ...

A widely available nutritional supplement derived from vitamin B5 may offer a promising new approach to treating psoriasis, ...

A recent pilot study published in the Journal of Indian Association of Pediatric Surgeons in October 2026 identified specific ...

In the last three years, a total of 477 students admitted to various postgraduate and super-speciality medical courses at 10 of the country’s most prestigious medical schools have left ...

NBEMS will declare the FMGE October 2026 results by November 30, according to the information bulletin.The October 2026 FMGE was conducted on October 31, 2026.For more details, check out the ...

Pennsylvania: Jubilant Therapeutics has announced that preliminary clinical data from its Phase 1/2 study of JBI-802, an investigational first-in-class oral dual LSD1/HDAC6 inhibitor, have ...

The Directorate General of Medical Education and Training (DGME), Uttar Pradesh, has released the seat matrix for the stray ...

In a recent order, the Supreme Court has issued notice on a plea filed by two medical colleges seeking a reduction in the ...

Bengaluru: The US FDA ‌on Monday informed patients and healthcare providers of a potential increased risk of a serious eye ...

The Delhi State Consumer Disputes Redressal Commission has directed a Delhi-based hospital to pay Rs 15 lakh in compensation ...